Bawik, Natividad V.

HRN: 25-30-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/21/2024
06/28/2024
IV INFUSION
2 25gm
Q8H
CAP HR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: